Hapvida Participações e Investimentos S.A. (BCBA:HAPV3)
Argentina · Delayed Price · Currency is ARS | Market Cap | 966.69B -81.3% |
| Revenue (ttm) | 9.11T +82.3% |
| Net Income | -49.65B |
| EPS | -100.93 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 7.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,601 |
| Open | 2,180.00 |
| Previous Close | 2,239.00 |
| Day's Range | 2,154.00 - 2,250.00 |
| 52-Week Range | 2,000.00 - 11,800.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |
About BCBA:HAPV3
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil. [Read more]
Financial Performance
In 2025, BCBA:HAPV3's revenue was 31.58 billion, an increase of 9.21% compared to the previous year's 28.91 billion. Losses were -141.75 million, -78.17% less than in 2024.
Financial numbers in BRL Financial StatementsNews
Hapvida Participações e Investimentos Earnings Call Transcript: Q2 2026
Transformation plan targets margin recovery, cash generation, and deleveraging, with Q2 net revenue up 3.9% year-over-year and adjusted EBITDA at BRL 504 million. Litigation and portfolio cleanup weigh on results, but management expects improvements over the next 12 months.
Hapvida Participações e Investimentos Slides: Q2 2026
Hapvida Participações e Investimentos has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
Hapvida Participações e Investimentos Earnings release: Q2 2026
Hapvida Participações e Investimentos released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Hapvida Participações e Investimentos Document: Q2 2026
Hapvida Participações e Investimentos filed a regulatory document on August 13, 2026 disclosing important business information.
Hapvida Participacoes upgraded to Buy from Hold at Jefferies
Jefferies upgraded Hapvida Participacoes (HAPVY) to Buy from Hold with a price target of R$19, down from R$31.50. 2025 was “a perfect storm” as Hapvida faced a convergence of commercial,…
Hapvida Participações e Investimentos Earnings Call Transcript: Q1 2026
Q1 2026 saw improved operational discipline, higher average ticket, and strong cash generation despite a net member loss and ongoing cost pressures. Strategic focus remains on margin protection, asset optimization, and deleveraging amid a competitive market.
Hapvida Participações e Investimentos Earnings release: Q1 2026
Hapvida Participações e Investimentos released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Hapvida Participações e Investimentos Slides: Q1 2026
Hapvida Participações e Investimentos has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.
Hapvida Participacoes downgraded to Neutral from Outperform at Bradesco BBI
Bradesco BBI downgraded Hapvida Participacoes (HAPVY) to Neutral from Outperform with a R$14 price target
Hapvida Participações e Investimentos Slides: Investor presentation
Hapvida Participações e Investimentos has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.
Hapvida Participações e Investimentos Earnings Call Transcript: Q4 2025
Q4 2025 results missed expectations due to high MLR and weak member growth, especially in competitive regions. Transformation initiatives, stricter capital discipline, and a CEO transition are underway, with 2026 focused on margin recovery, operational efficiency, and selective growth.
Hapvida Participações e Investimentos Earnings release: Q4 2025
Hapvida Participações e Investimentos released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.
Hapvida Participações e Investimentos Slides: Q4 2025
Hapvida Participações e Investimentos has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 19, 2026.
Brazil's Hapvida shares plunge nearly 40% after disappointing Q3 results
Brazilian health provider Hapvida (HAPV3) declared a net profit of R$338 million on Wednesday night, but the third quarter of 2025 proved to be quite disappointing. According to local media outlet Inf...
Hapvida Participações e Investimentos Earnings Call Transcript: Q3 2025
Q3 2025 saw margin pressure from higher utilization and new unit costs, but customer satisfaction and operational metrics improved. Membership growth was below expectations, with robust corporate gains offset by tough competition in other segments. Margin recovery and cost dilution are expected as new units mature and pricing adjustments take effect.
Hapvida Participações e Investimentos Earnings release: Q3 2025
Hapvida Participações e Investimentos released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
Hapvida Participações e Investimentos Slides: Q3 2025
Hapvida Participações e Investimentos has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 13, 2025.